Marinus Pharmaceuticals I... (MRNS)
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 30.99M | 25.48M | 15.35M | 1.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K |
| Cost of Revenue | 1.93M | 340K | 1.48M | 50.51M | 503K | 127K | 126K | 23K | 11K | n/a | n/a | n/a |
| Gross Profit | 29.05M | 25.14M | 13.87M | -48.79M | -503K | -127K | -126K | -23K | -11K | n/a | n/a | 100K |
| Operating Income | -131.49M | -112.79M | -96.93M | -67.94M | -54.42M | -37.18M | -19.04M | -28.24M | -24.43M | -11.92M | -5.38M | -1.43M |
| Interest Income | 8.11M | 2.35M | 80K | 499K | 354K | 454K | 324K | 128K | 64K | 12K | 19.05K | 2.66K |
| Pretax Income | -142.94M | -16.43M | -98.78M | -67.47M | -54.12M | -36.73M | -18.9M | -28.64M | -24.85M | -10.83M | -5.27M | -1.41M |
| Net Income | -141.41M | -19.82M | -101.66M | -66.64M | -53.77M | -36.73M | -18.9M | -28.64M | -24.85M | -10.83M | -5.27M | -1.41M |
| Selling & General & Admin | 61.15M | 56.84M | 37.28M | 18.55M | 11.46M | 8.79M | 6.67M | 6.24M | 5.52M | 3.23M | 1.23M | 685.1K |
| Research & Development | 99.39M | 79.91M | 73.52M | 51.11M | 42.97M | 28.39M | 12.38M | 22M | 18.92M | 8.69M | 4.15M | 845.56K |
| Other Expenses | n/a | 1.17M | 657K | -37K | -53K | -1K | -20K | -65K | -7K | 1.19M | 152.69K | 336.05K |
| Operating Expenses | 160.54M | 137.93M | 110.8M | 69.66M | 54.42M | 37.18M | 19.04M | 28.24M | 24.43M | 11.92M | 5.35M | 1.53M |
| Interest Expense | 16.89M | 10.67M | 2.58M | n/a | n/a | n/a | 159K | 464K | 475K | 117K | 90.61K | 320.78K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 162.47M | 138.27M | 112.28M | 69.66M | 54.42M | 37.18M | 19.04M | 28.24M | 24.43M | 11.92M | 5.35M | 1.53M |
| Income Tax | -1.54M | 3.39M | 2.88M | -833K | -354K | 453K | 13K | 399K | 468K | 1.31M | -27.82K | 656.83K |
| Shares Outstanding (Basic) | 53.75M | 39.07M | 36.7M | 27.27M | 13.63M | 10.22M | 5.89M | 4.87M | 3.73M | 1.54M | 2.02M | 2.02M |
| Shares Outstanding (Diluted) | 53.75M | 39.07M | 36.7M | 27.27M | 13.63M | 10.22M | 5.89M | 4.87M | 3.73M | 1.54M | 2.02M | 2.02M |
| EPS (Basic) | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 | -3.21 | -5.88 | -6.66 | -7.04 | -2.61 | -0.7 |
| EPS (Diluted) | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 | -3.21 | -5.88 | -6.66 | -7.04 | -2.61 | -0.7 |
| EBITDA | -125.5M | -5.09M | -95.53M | -66.88M | -54.42M | -36.6M | -18.61M | -28.16M | -24.36M | -10.71M | -5.2M | -1.07M |
| Depreciation & Amortization | 551K | 669K | 667K | 598K | 503K | 127K | 126K | 23K | 11K | 5K | 9.79K | 17.9K |